Meet Dr. Subhash BanerjeeInterventional Cardiologist in Dallas
Interventional cardiologist and endovascular specialist Subhash Banerjee, M.D., has a passion for helping his patients by leveraging the most advanced, forward-thinking research and treatments available.
An internationally recognized expert in his field, Dr. Banerjee is highly specialized in complex cardiovascular procedures that combat the growing epidemic of heart and vascular disease.
He has dedicated his career to minimally invasive coronary artery, peripheral artery, and transcatheter aortic valve replacement procedures (TAVR). TAVR is a breakthrough new treatment option for many patients who wouldn’t be candidates for traditional open surgery.
Dr. Banerjee is also a leading expert in high-risk percutaneous coronary interventions with hemodynamic support devices, or heart pumps, as well as percutaneous treatment of coronary and peripheral artery chronic total occlusions.
“Everyone has a strength,” he says. “These procedures require in-depth and precise knowledge of multitudes of devices and technologies. And my strength is that I have been completely dedicated to these complex procedures for the past 15 years. I didn’t want to dilute myself by doing multiple things. So I do these procedures every day.”
That singular focus allows Dr. Banerjee to provide the highest standard of care to his cardiology patients, some of whom undergo extensive, multi-hour procedures in order to regain full heart function. He also makes sure to stay abreast of the latest developments in heart care. His dedication to leading-edge treatments is the reason he is so heavily involved in research.
A Lifelong Love of Research
In his decades of research, Dr. Banerjee has led many landmark medical research trials and has published more than 290 peer-reviewed manuscripts and book chapters.
It’s his love for research that helped draw him to the field of interventional cardiology. Dr. Banerjee studied internal medicine and cardiovascular diseases prior to starting his career as a basic scientist. When he was awarded a prestigious grant from the American Heart Association in 2000, he had the chance to research adult stem cells and their role in repairing heart and blood vessels.
“While getting involved in vascular biology, I developed a keen interest in how I could actually use the research to change the course of disease,” he says. “That’s what drew me to minimally invasive endovascular procedures. The research inspired me to want to actually affect those changes in real human patients.”
The American Heart Association research led him to a fellowship in interventional cardiology, which became his life’s work.
“My whole focus has been to be one of the few people who is immersed so deeply in these complex procedures that when any new technology or new treatment comes along, we can quickly start learning it and bring those new technologies to our institution,” he says.
As heart and vascular disease become increasingly common, more research is being conducted into these conditions than ever before. And the progress is significant.
“The past five years are the first five years where we have seen a decline in death rates from heart and vascular disease,” Dr. Banerjee says.
That is due in large part to new research being put into practice that improves patient outcomes, shortens recovery time, and advances management of risk factors.
“For example, the first generation of biodegradable stents is being issued and approved by the FDA. Because most stents are made out of metal, they are there for the entire life of the patient,” Dr. Banerjee says. “But biodegradable stents completely disappear after six or eight months, and the blood vessel assumes its normal function.”
A strategy buff who grew up playing chess and who even considered becoming a professional player, Dr. Banerjee still enjoys the challenge of solving a complex problem in both his work and personal life. One of his favorite ways to challenge himself is to learn a new language. Aside from English, he has learned Hindi, Bengali, and Russian.